# FDA Inspection 669021 - Bristol-Myers Squibb Manufacturing Company Unlimited Company - June 25, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/bristol-myers-squibb-manufacturing-company-unlimited-company/fe7bd86b-7509-4147-a145-c7d29d632ded/
Source feed: FDA_Inspections

> FDA Inspection 669021 for Bristol-Myers Squibb Manufacturing Company Unlimited Company on June 25, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 669021
- Company Name: Bristol-Myers Squibb Manufacturing Company Unlimited Company
- Inspection Date: 2010-06-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1121802 - 2020-02-14](https://www.globalkeysolutions.net/api/records/fda_inspections/bristol-myers-squibb-manufacturing-company-unlimited-company/edde3b1f-ffdb-4eb9-86ba-7dfb48db7f7d/)
- [FDA Inspection 1051117 - 2018-04-27](https://www.globalkeysolutions.net/api/records/fda_inspections/bristol-myers-squibb-manufacturing-company-unlimited-company/105141ec-8990-4937-bc2f-e314d1fa1be6/)
- [FDA Inspection 993014 - 2016-11-18](https://www.globalkeysolutions.net/api/records/fda_inspections/bristol-myers-squibb-manufacturing-company-unlimited-company/370f4219-d7b2-489a-8328-b3cd7127553f/)
- [FDA Inspection 956226 - 2015-12-09](https://www.globalkeysolutions.net/api/records/fda_inspections/bristol-myers-squibb-manufacturing-company-unlimited-company/3830dbd0-d85b-4333-b61f-7eaa4cfc8265/)
- [FDA Inspection 866747 - 2014-02-20](https://www.globalkeysolutions.net/api/records/fda_inspections/bristol-myers-squibb-manufacturing-company-unlimited-company/e1462b05-60fc-4070-b0ab-c049e8c96029/)

Company: https://www.globalkeysolutions.net/companies/bristol-myers-squibb-manufacturing-company-unlimited-company/ccfba5f2-eeac-4000-bb3a-437eefc63c7c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c